| 1-P08 | The HPV 16 complete genome in two cervical progressive lesions from a 39-Year-Old Woman differ from each other. | Filomena Silveira | |
| 1-P10 | Comparative evaluation of three HPV genotyping assays on FFPE samples of head and neck cancer | Jol Mossong | |
| 1-P11 | Effectiveness of HPV vaccine for the prevention of cervical abnormalities in Saitama City, Japan in 2015 | Daisuke Hotta | |
| 1-P09 | History and future of HPV College | Tomas Fait | |
| 1-P03 | Fisher cone biopsy in the management of cervical cancer precursors | Alfred Drr | |
| 2-P03 | Obstetric outcome after conization or LLETZ : a retrospective study in the university hospital of Leuven | Hannah Verschuere | |
| 2-P12 | Improving strategies and test algorithms for HPV diagnostics | Francisco Aliaga-Lozano | |
| 2-P09 | Population-based study about the knowledge of women on secondary prevention of cervical cancer | Mónica Hernández | |
| 2-P16 | Validation of a new method for high-risk HPV detection with the XPERT HPV assay in in PAP-SPIN medium | Claude Cuvelier | |
| 2-P11 | The potential impact of papillomavirus vaccines in operable cervical tumours | Mariana Mouraz Lopes dos Santos | |
| 3-P15 | Performance of the ONCOE6 test for high-grade cervical disease and cancer detection among Honduran women | Annabelle Ferrera Boza | |
| 3-P16-A | Application of Robotic Single-Site Surgery for benign ovarian tumor | S.H. Kwon | |
| 3-P09 | Study about the anxiety generated by the result of screening techniques of cervical cancer | Leyre Ruiz | |
| 3-P05 | Evaluation of sample cellularity and nucleic acids stability using Copan Enat medium associated with FLOQSWABS: self-collected versus clinician-vaginal sampling. | Marianna Martinelli | |
| 4-P07 | HPV and breast canceris there a relationship? | DELGADO GARCÍA SILVIA | |
| 4-P11 | 9-valent HPV vaccine development: innovative regulatory approach using a phase IIB/III design and an immunological bridging to establish efficacy | Amita Joshi | |
| 5-P07 | Epidemiology of hospitalizations related to cervical cancer in Spain (2009-2013) | Ruth Gil-Prieto | |
| 6-P07 | HPV-related cancer in Norway: secular incidence trends and preventive potential of HPV vaccination | Bo Terning Hansen | |
| 7-P01 | Estimating the management cost of cervical intraepithelial neoplasia in the UK | Mathieu uhart | |
| 7-P11 | The impact of the vaccination with bivalent HPV vaccine after electrosurgical conization in preventing of HPV infection in patients with high grade cervical intraepithelial neoplasia. | Natalya Volodko | |
| 7-P07 | Cervical cancer incidence and mortality in the Russian Federation | Susanna Kharit | |
| 9-P11 | Public health impact and cost effectiveness of a universal vaccination programme with a nonavalent HPV vaccine in Germany | Mathieu Uhart | |
| 9-P17 | Current standards and options for national cervical cancer screening programme in Croatia | Josko Zekan | |
| 12-P07 | Anal High Risk HPV: Gender Comparison For Detection In Puerto Rican Population | ALEXANDRA ROSADO | |
| 15-P07 | Genital warts in Scandinavian women before and after implementation of HPV vaccination | Christian Munk | |
| 184-P | Expression of vascular endothelial growth factor- C and podoplanin in squamous intraepithelial lesion | Neila Gois Speck | |
| 268-P | Evaluation of the management of HR-HPV/paptest-women: results at 1-year recall | Claudio Di Cristofano | |
| 293-P | Results of conventional cytology pap smear versus liquid-based cytology associated with HPV DNA testing in women with uterine cervical ectopy | Fernandes Silvana | |
| 313-P | Preliminary evaluation of cervical cancer screening by cytology and HPV testing in north-western region of Romania | Ofelia Suteu | |
| 393-P | Health outcome and budget impact analysis of a combined cervical screening strategy based on primary HPV screening and triage with dual stain cytology in Belgium | Katleen Vandeweyer | |
| 463-P | Evaluation of Seegene Anyplex II HPV genotyping assays using cervical samples | Sepehr Tabrizi | |
| 595-P | Comparative study of the immunomodulatory properties of different coriolus versicolor-based formulations administered orally or topically in the vagina in healthy mice | Josep Combalia | |

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|